Trial · NCT01605136
Results by group46
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 46
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Duration of Direct Sunlight Exposure Between 10:00 and 18:00 Hours on Days When no Pain Was Experienced (Pain Score of 0). | Afamelanotide | 69.4 | Full Range 0 to 650.50 | hours | |
| Duration of Direct Sunlight Exposure Between 10:00 and 18:00 Hours on Days When no Pain Was Experienced (Pain Score of 0). | Placebo | 40.8 | Full Range 0.25 to 224.00 | hours | |
| Combined Sun Exposure and Phototoxic Pain | Afamelanotide | 80.0 | Full Range 0.5 to 825.0 | hours | |
| Combined Sun Exposure and Phototoxic Pain | Placebo | 51.0 | Full Range 1.25 to 251.0 | hours | |
| Sun Exposure | Afamelanotide | 83.50 | Full Range 0.50 to 825.00 | hours | |
| Sun Exposure | Placebo | 65.25 | Full Range 3.50 to 278.50 | hours | |
| Quality of Life Score | Afamelanotide | DLQI - Day 0 (baseline) | 10.0 | Full Range 0 to 26 | units on a scale |
| Quality of Life Score | Placebo | DLQI - Day 0 (baseline) | 11.0 | Full Range 0 to 22 | units on a scale |
| Quality of Life Score | Afamelanotide | DLQI - Day 60 | 2.0 | Full Range 0 to 21 | units on a scale |
| Quality of Life Score | Placebo | DLQI - Day 60 | 4.0 | Full Range 0 to 21 | units on a scale |
| Quality of Life Score | Afamelanotide | DLQI - Day 120 | 0.5 | Full Range 0 to 16 | units on a scale |
| Quality of Life Score | Placebo | DLQI - Day 120 | 2.5 | Full Range 0 to 19 | units on a scale |
| Quality of Life Score | Afamelanotide | DLQI - Day 180/Early Termination | 1.0 | Full Range 0 to 16 | units on a scale |
| Quality of Life Score | Placebo | DLQI - Day 180/Early Termination | 1.0 | Full Range 0 to 14 | units on a scale |
| Quality of Life Score | Afamelanotide | EPP QOL - Day 0 (baseline) | 19.4 | Full Range 0 to 83 | units on a scale |
| Quality of Life Score | Placebo | EPP QOL - Day 0 (baseline) | 22.2 | Full Range 3 to 81 | units on a scale |
| Quality of Life Score | Afamelanotide | EPP QOL - Day 60 | 77.8 | Full Range 0 to 100 | units on a scale |
| Quality of Life Score | Placebo | EPP QOL - Day 60 | 55.6 | Full Range 6 to 97 | units on a scale |
| Quality of Life Score | Afamelanotide | EPP QOL - Day 120 | 81.9 | Full Range 17 to 100 | units on a scale |
| Quality of Life Score | Placebo | EPP QOL - Day 120 | 61.1 | Full Range 6 to 97 | units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01605136/results